PT - JOURNAL ARTICLE AU - Bell, James AU - Lartey, Belinda AU - Spickernell, Gemma AU - Darrell, Natasha AU - Salt, Frances AU - Gardner, Cassie AU - Richards, Emily AU - Fasakin, Lanre AU - Egbeniyi, Shadrach AU - Odongo, Emmanuel AU - Ssenkungu, James AU - Kouadio, Rigobert Kotchi AU - Cissé, Mamadi AU - Rérambyah, Axel Bruno Ayiya Igowa AU - Adou, Maikol AU - West, Rebecca AU - Sharma, Sunny TI - Applying a Socio-Ecological Model to Understand Factors Impacting Demand for Childhood Vaccinations in Nigeria, Uganda, and Guinea AID - 10.1101/2022.08.15.22278784 DP - 2022 Jan 01 TA - medRxiv PG - 2022.08.15.22278784 4099 - http://medrxiv.org/content/early/2022/08/16/2022.08.15.22278784.short 4100 - http://medrxiv.org/content/early/2022/08/16/2022.08.15.22278784.full AB - Vaccines have reduced child mortality across the world, but low levels of demand for vaccination threatens to undermine progress. Existing frameworks to understand demand tend to prioritise caregivers’ decision-making processes. We aimed to build a wider understanding of vaccine demand by applying an adapted socio-ecological model to analyse 158 interviews with caregivers and fathers of young children, and community influencers in Nigeria, Uganda, and Guinea. We found that several factors come together to inform a caregiver’s demand for vaccination, including their familial and social relationships, their interactions with government and healthcare institutions, and the wider social and cultural norms in their communities. The study suggests that interventions targeted at families and communities instead of individuals could be effective. The results could be used to ensure that vaccine demand frameworks used by researchers and intervention designers are comprehensive and consider a wider range of influences on the caregiver.Competing Interest StatementAll authors work for market and social research organisations that carry out research on behalf of commercial companies, including in the field of vaccines.Funding StatementThe authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The work was supported by the Bill and Melinda Gates Foundation [Investment ID INV-001411].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committees of Makerere University College of Health Sciences in Uganda, the National Health Research Ethics Committee of Nigeria, and the Comité Nationale d'Ethique pour la Recherche en Santé in Guinea gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesReasonable data requests will be considered by the authors